The Effect of Antipsychotics on Cognition in Schizophrenia-A Current Narrative Review.
Petru Fabian LunguCorina Miruna LunguAlin CiobicaIoana Miruna BalmusRaluca VitalaruIoannis A MavroudisRomeo Petru DobrinMirela CimpeanuIrina Luciana GurzuPublished in: Brain sciences (2024)
The majority of schizophrenia-affected individuals display deficiencies in multiple cognitive domains such as attention, working memory, long-term memory, and learning, deficiencies that are stable throughout the disease. The purpose of this narrative review was to examine the effect of antipsychotics on several cognitive domains affected by schizophrenia. Methods: We searched MEDLINE, Elsevier, Scopus, and DOAJ databases for randomized controlled trials and other studies investigating the effects of typical and atypical antipsychotics on cognition in patients with schizophrenia in studies conducted in the last decade. Results: The majority of studies included in this review showed that antipsychotics (especially SGAs) have positive effects on both cognition and general psychopathology of schizophrenia. We mention that treatment with antipsychotic substances represents an ongoing effort of the researchers, who are constantly searching for the best approach to meet the mental health needs of schizophrenia patients. Conclusions: Even with those positive results, it should be noted that more studies are needed in order to fully observe the various effects of certain antipsychotic substances on cognition.
Keyphrases
- working memory
- bipolar disorder
- mental health
- mild cognitive impairment
- case control
- end stage renal disease
- randomized controlled trial
- white matter
- transcranial direct current stimulation
- ejection fraction
- newly diagnosed
- attention deficit hyperactivity disorder
- drinking water
- chronic kidney disease
- peritoneal dialysis
- multiple sclerosis
- machine learning
- big data
- anorexia nervosa